SCHEMBL31420547

SCHEMBL31420547

COCCN(CCNC(=O)OC(C)(C)C)CCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.50
SIGMAR1 Q99720 3/20 0.46
AKT1 P31749 2/20 0.44
CKS1B P61024 1/20 0.44
SKP1 P63208 1/20 0.44
SKP2 Q13309 1/20 0.44
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
NAMPT P43490 1/20 0.43
CTSK P43235 2/20 0.42
CTSS P25774 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31420633 0.84 TDP1 (0.47) IDO1CKS1BSKP1SKP2NPSR1
SCHEMBL4541522 0.81 IDO1 (0.52) IDO1SIGMAR1AKT1CKS1BSKP1
SCHEMBL20506777 0.81 AKT1 (0.58) IDO1SIGMAR1AKT1CKS1BSKP1
SCHEMBL15613432 0.80 SYK (0.58) IDO1AKT1CKS1BSKP1SKP2
SCHEMBL31165330 0.80 SYK (0.58) IDO1AKT1CKS1BSKP1SKP2
SCHEMBL31687552 0.80 ACKR3 (0.54) IDO1SIGMAR1AKT1CTSKNPSR1
SCHEMBL572740 0.79 IDO1 (0.60) IDO1SIGMAR1NAMPTCTSKCTSS
SCHEMBL8399579 0.79 AKT1 (0.56) IDO1SIGMAR1AKT1CKS1BSKP1
SCHEMBL11990357 0.78 SMN1; SMN2 (0.64) IDO1AKT1CKS1BSKP1SKP2
SCHEMBL8398778 0.78 TDP1 (0.44) IDO1SIGMAR1CKS1BSKP1SKP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 US disclosed
WO-2025064718-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS IDO1 4534/4885SIGMAR1 4458/4885AKT1 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.